WebNov 7, 2024 · November 7, 2024 — Laborie Medical Technologies Corp (Laborie), a specialist medical technology company, announced today that the American Medical … WebThe Optilume® urethral drug-coated balloon was developed in response to severe patient and physician dissatisfaction with current urethral stricture solutions. Optilume® technology combines...
The technology Optilume for anterior urethral strictures
WebProcedural Guide Video - Optilume® Urethral Drug Coated Balloon for Urethral Stricture Treatment Laborie Urology & Urogynecology 3.81K subscribers Subscribe 139 Save 9.8K views 1 year ago... WebApr 12, 2024 · Optilume is the world’s first Drug Coated Balloon approved by the FDA to treat patients with Urethral Strictures. The Optilume Urethral Drug Coated Balloon technology simultaneously dilates and delivers an anti-proliferative medicine to the urethral stricture. ... Laborie’s Optilume® Issued Category 1 CPT Code by American Medical … mercy money
Optilume (Drug Coated Balloon) for the Treatment of Urethral …
WebApr 10, 2024 · Approval Order Statement. Approval of the Optilume® Urethral Drug Coated Balloon. The device is used to treat patients with obstructive urinary symptoms associated with anterior urethral stricture. It is designed to be used in adult males for urethral strictures of less than or equal to 3 cm in length. Approval Order. WebMar 17, 2024 · The balloon is coated on its outer surface with paclitaxel, which is then transferred to the urethral wall and is theorised to prevent the stricture from recurring. The main evidence supporting the FDA approval comes from the ROBUST III study, a prospective, randomised, multicentre, single-blind trial comparing the Optilume device … WebDec 1, 2024 · Optilume (Drug Coated Balloon) for the Treatment of Urethral Stricture Conditions Number: SUR710.026 Effective Date: 12-01-2024 Coverage: *CAREFULLY CHECK STATE REGULATIONS AND/OR THE MEMBER CONTRACT* how old is reetlol